Justice Dept. Sues AmerisourceBergen Over Role in Opioid Crisisnews2022-12-29T23:46:45+00:00December 29th, 2022|The New York Times|
Congressional Investigation into Alzheimer’s Drug Aduhelm Faults the F.D.A. and Biogennews2022-12-29T19:54:35+00:00December 29th, 2022|The New York Times|
Covid en China: el abrupto aumento de casos impulsa una escasez de medicinasnews2022-12-26T08:00:14+00:00December 26th, 2022|The New York Times|
The F.D.A. Now Says It Plainly: Morning-After Pills Are Not Abortion Pillsnews2022-12-24T01:22:45+00:00December 24th, 2022|The New York Times|
‘Tripledemic’ Forces Pharmacies to Limit Purchases of Children’s Pain Relieversnews2022-12-20T19:45:22+00:00December 20th, 2022|The New York Times|
China’s Abrupt Covid Pivot Leaves Many Without Medicinesnews2022-12-20T10:30:40+00:00December 20th, 2022|The New York Times|
They Created a Drug for Susannah. What About Millions of Other Patients?news2022-12-19T22:40:09+00:00December 19th, 2022|The New York Times|
Cold and Flu Medicine: What to Stock for the ‘Tripledemic’news2022-12-17T10:00:23+00:00December 17th, 2022|The New York Times|
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?news2022-12-16T10:00:26+00:00December 16th, 2022|The New York Times|
Los bloqueadores de pubertad pueden ayudar a menores trans. ¿A qué costo?news2022-12-14T14:30:22+00:00December 14th, 2022|The New York Times|
